Association of plasma microRNA levels with different collateral circulation degree in chronic total occlusion patients with coronary artery disease: a pilot study
Aim. To investigate the association of 10 circulating plasma microRNAs with collateral flow degree in chronic total occlusion (CTO) patients with coronary artery disease (CAD). Materials and methods. Plasma expression levels of 10 circulating miRNAs were measured by real-time PCR using Taqman techno...
Saved in:
| Published in | Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika Vol. 23; no. 7; p. 4086 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English Russian |
| Published |
SILICEA-POLIGRAF» LLC
01.08.2024
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1728-8800 2619-0125 |
| DOI | 10.15829/1728-8800-2024-4086 |
Cover
| Abstract | Aim.
To investigate the association of 10 circulating plasma microRNAs with collateral flow degree in chronic total occlusion (CTO) patients with coronary artery disease (CAD).
Materials and methods.
Plasma expression levels of 10 circulating miRNAs were measured by real-time PCR using Taqman technology in a sample of 43 subjects. The study included patients with CAD and CTO with good (n=13) or poor (n=10) coronary collateral circulation (CCC) based on Rentrop classification and a control group of patients without significant coronary stenosis (n=20).
Results.
Significant differences in expression levels were found for 7 circulating miRNAs in patients with CTO and good CCC and for 5 microRNAs in the combined group of patients with CTO compared to the control group. Among the 7 microRNAs, decreased expression of hsa-miR-126-5p, hsa-miR-146a-5p, hsa-miR-155-5p, hsa-miR-15b-5p, hsa-miR-21-5p, hsa-miR-23a-3p and increased expression of hsa-miR-451a were detected. For the first time, we showed that the level of 2 microRNAs (hsa-miR-23a-3p, hsa-miR-21-5p) is significantly reduced and the level of hsa-miR-451a is increased in patients with CAD with good CCC.
Conclusion.
Plasma microRNAs with significant differences obtained can be used for further studies on a larger sample size as candidate biomarkers for assessing the severity of ССС in the presence of CTO. |
|---|---|
| AbstractList | Aim.
To investigate the association of 10 circulating plasma microRNAs with collateral flow degree in chronic total occlusion (CTO) patients with coronary artery disease (CAD).
Materials and methods.
Plasma expression levels of 10 circulating miRNAs were measured by real-time PCR using Taqman technology in a sample of 43 subjects. The study included patients with CAD and CTO with good (n=13) or poor (n=10) coronary collateral circulation (CCC) based on Rentrop classification and a control group of patients without significant coronary stenosis (n=20).
Results.
Significant differences in expression levels were found for 7 circulating miRNAs in patients with CTO and good CCC and for 5 microRNAs in the combined group of patients with CTO compared to the control group. Among the 7 microRNAs, decreased expression of hsa-miR-126-5p, hsa-miR-146a-5p, hsa-miR-155-5p, hsa-miR-15b-5p, hsa-miR-21-5p, hsa-miR-23a-3p and increased expression of hsa-miR-451a were detected. For the first time, we showed that the level of 2 microRNAs (hsa-miR-23a-3p, hsa-miR-21-5p) is significantly reduced and the level of hsa-miR-451a is increased in patients with CAD with good CCC.
Conclusion.
Plasma microRNAs with significant differences obtained can be used for further studies on a larger sample size as candidate biomarkers for assessing the severity of ССС in the presence of CTO. Aim. To investigate the association of 10 circulating plasma microRNAs with collateral flow degree in chronic total occlusion (CTO) patients with coronary artery disease (CAD).Materials and methods. Plasma expression levels of 10 circulating miRNAs were measured by real-time PCR using Taqman technology in a sample of 43 subjects. The study included patients with CAD and CTO with good (n=13) or poor (n=10) coronary collateral circulation (CCC) based on Rentrop classification and a control group of patients without significant coronary stenosis (n=20).Results. Significant differences in expression levels were found for 7 circulating miRNAs in patients with CTO and good CCC and for 5 microRNAs in the combined group of patients with CTO compared to the control group. Among the 7 microRNAs, decreased expression of hsa-miR-126-5p, hsa-miR-146a-5p, hsa-miR-155-5p, hsa-miR-15b-5p, hsa-miR-21-5p, hsa-miR-23a-3p and increased expression of hsa-miR-451a were detected. For the first time, we showed that the level of 2 microRNAs (hsa-miR-23a-3p, hsa-miR-21-5p) is significantly reduced and the level of hsa-miR-451a is increased in patients with CAD with good CCC.Conclusion. Plasma microRNAs with significant differences obtained can be used for further studies on a larger sample size as candidate biomarkers for assessing the severity of ССС in the presence of CTO. |
| Author | Meshkov, A. N. Arablinsky, N. A. Shukurov, F. B. Feshchenko, D. A. Ershova, A. I. Vasilyev, D. K. Skirko, O. P. Drapkina, O. M. Kiseleva, A. V. Soplenkova, A. G. Kutsenko, V. A. Pokrovskaya, M. S. Sotnikova, E. A. Zharikova, A. A. |
| Author_xml | – sequence: 1 givenname: A. V. orcidid: 0000-0003-4765-8021 surname: Kiseleva fullname: Kiseleva, A. V. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 2 givenname: D. K. orcidid: 0000-0003-2602-5006 surname: Vasilyev fullname: Vasilyev, D. K. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 3 givenname: A. G. orcidid: 0000-0003-0703-146X surname: Soplenkova fullname: Soplenkova, A. G. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 4 givenname: F. B. orcidid: 0000-0001-7307-1502 surname: Shukurov fullname: Shukurov, F. B. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 5 givenname: E. A. orcidid: 0000-0002-8395-4146 surname: Sotnikova fullname: Sotnikova, E. A. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 6 givenname: D. A. orcidid: 0000-0003-3851-4544 surname: Feshchenko fullname: Feshchenko, D. A. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 7 givenname: V. A. orcidid: 0000-0001-9844-3122 surname: Kutsenko fullname: Kutsenko, V. A. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 8 givenname: N. A. orcidid: 0000-0002-7294-7274 surname: Arablinsky fullname: Arablinsky, N. A. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 9 givenname: O. P. orcidid: 0000-0003-3755-0279 surname: Skirko fullname: Skirko, O. P. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 10 givenname: A. A. orcidid: 0000-0003-0723-0493 surname: Zharikova fullname: Zharikova, A. A. organization: National Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State University – sequence: 11 givenname: A. I. orcidid: 0000-0001-7989-0760 surname: Ershova fullname: Ershova, A. I. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 12 givenname: M. S. orcidid: 0000-0001-6985-7131 surname: Pokrovskaya fullname: Pokrovskaya, M. S. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 13 givenname: A. N. orcidid: 0000-0001-5989-6233 surname: Meshkov fullname: Meshkov, A. N. organization: National Medical Research Center for Therapy and Preventive Medicine – sequence: 14 givenname: O. M. orcidid: 0000-0002-4453-8430 surname: Drapkina fullname: Drapkina, O. M. organization: National Medical Research Center for Therapy and Preventive Medicine |
| BookMark | eNp9kU1uFDEQhS0UpAwhN8jCF2jwT3vszm4UAYkUgYRgbbnL1YkjT3tke0BzHU4a90zCggUrS9Z7X72q946czWlGQq44-8CVEcNHroXpjGGsE0z0Xc_M-g1ZiTUfOsaFOiOrv4pzclnKE2OMG62k6Ffkz6aUBMHVkGaaJrqLrmwd3QbI6fvXDY34C2Ohv0N9pD5ME2acK4UUo6uYXaQQMuzjye_xISPSMFN4zGkOQGuqTZMA4r4sil0TNsALEFJTuXygLjfYoQ0o6ApeU0d3IaZKS937w3vydnKx4OXLe0F-fv704-a2u__25e5mc9-BaCt3cgDvATSI3msjR6VRj8KjctpPGnqtBsOFloOQXhkcpXQwTrKJvINBMXlB7k5cn9yT3eWwbdFscsEeP1J-sC1ngIh2xDZyNGvPxr43Ckdh2KiN0Ia7YYC-sa5PrHbGUjJOFkI9HqlmF6LlzB7Ls0s1dqnGLuXZpbxm7v8xv4b5r-0Zmwii8Q |
| CitedBy_id | crossref_primary_10_15829_1728_8800_2024_4190 crossref_primary_10_15829_1728_8800_2024_4214 |
| Cites_doi | 10.1016/j.tcm.2011.12.001 10.18053/jctres.05.201902.002 10.4314/ahs.v17i2.22 10.1161/CIRCRESAHA.108.171827 10.1007/s11033-022-07253-z 10.1038/s41598-018-19581-x 10.1111/jcmm.15001 10.15829/1728-8800-2021-3119 10.3389/fphar.2019.01500 10.1016/S0735-1097(85)80380-6 10.1097/MCA.0000000000000115 10.4061/2011/532915 10.1038/emm.2014.81 10.1038/srep42916 10.1016/j.lfs.2018.06.001 10.1002/ctm2.585 10.1016/j.biocel.2022.106294 10.3390/biom10101354 10.1371/journal.pone.0137035 10.1371/journal.pone.0216363 10.1161/CIRCRESAHA.110.226357 10.1161/ATVBAHA.116.308905 10.1073/pnas.1105254108 10.3389/fphys.2019.00123 10.3389/fcvm.2022.826478 10.18632/oncotarget.18308 10.1002/jnr.24487 10.18632/aging.101766 10.1155/2016/4285942 10.3389/fcvm.2021.632392 10.1016/j.ehj.2004.03.005 10.1016/j.mrfmmm.2014.01.001 10.1016/j.pneurobio.2013.11.004 10.2217/bmm-2016-0282 10.1161/CIRCRESAHA.109.215566 10.1006/meth.2001.1262 10.1016/j.ymeth.2012.09.015 10.1016/j.devcel.2008.07.002 10.21614/jtmr-20-3-44 10.2174/1568026623666221221124530 10.3390/biom11070962 10.1016/j.bbrc.2009.06.075 10.3390/ijms21103485 10.3390/ijms21030700 10.1371/journal.pone.0181562 10.3390/diagnostics11020318 10.1371/journal.pone.0080738 10.1186/s13019-021-01700-x 10.3389/fcvm.2021.770163 10.1016/j.jstrokecerebrovasdis.2021.106033 |
| ContentType | Journal Article |
| DBID | AAYXX CITATION DOA |
| DOI | 10.15829/1728-8800-2024-4086 |
| DatabaseName | CrossRef DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2619-0125 |
| ExternalDocumentID | oai_doaj_org_article_be208b86d0b4485eb280b782781a99c4 10_15829_1728_8800_2024_4086 |
| GroupedDBID | 29B 5GY 642 AAYXX ADBBV AHDHK ALMA_UNASSIGNED_HOLDINGS BCNDV CITATION GROUPED_DOAJ VCL VIT |
| ID | FETCH-LOGICAL-c2086-39cddcc7c24d783b57e7b2de5a7df7c475981273923d58eb33acbf3e7bdac9503 |
| IEDL.DBID | DOA |
| ISSN | 1728-8800 |
| IngestDate | Wed Aug 27 01:30:51 EDT 2025 Wed Oct 01 03:03:22 EDT 2025 Thu Apr 24 23:09:32 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English Russian |
| License | https://cardiovascular.elpub.ru/jour/about/editorialPolicies#openAccessPolicy |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2086-39cddcc7c24d783b57e7b2de5a7df7c475981273923d58eb33acbf3e7bdac9503 |
| ORCID | 0000-0003-0723-0493 0000-0001-6985-7131 0000-0001-7307-1502 0000-0002-8395-4146 0000-0003-2602-5006 0000-0003-3851-4544 0000-0002-4453-8430 0000-0002-7294-7274 0000-0003-4765-8021 0000-0001-5989-6233 0000-0001-7989-0760 0000-0003-3755-0279 0000-0003-0703-146X 0000-0001-9844-3122 |
| OpenAccessLink | https://doaj.org/article/be208b86d0b4485eb280b782781a99c4 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_be208b86d0b4485eb280b782781a99c4 crossref_citationtrail_10_15829_1728_8800_2024_4086 crossref_primary_10_15829_1728_8800_2024_4086 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-01 |
| PublicationDateYYYYMMDD | 2024-08-01 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika |
| PublicationYear | 2024 |
| Publisher | SILICEA-POLIGRAF» LLC |
| Publisher_xml | – name: SILICEA-POLIGRAF» LLC |
| References | ref13 ref12 ref15 ref14 ref11 ref10 ref17 ref16 ref19 ref18 ref51 ref50 ref46 ref45 ref48 ref47 ref42 ref41 ref44 ref43 ref49 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 ref35 ref34 ref37 ref36 ref31 ref30 ref33 ref32 ref2 ref1 ref39 ref38 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 |
| References_xml | – ident: ref8 doi: 10.1016/j.tcm.2011.12.001 – ident: ref48 doi: 10.18053/jctres.05.201902.002 – ident: ref43 doi: 10.4314/ahs.v17i2.22 – ident: ref6 doi: 10.1161/CIRCRESAHA.108.171827 – ident: ref31 doi: 10.1007/s11033-022-07253-z – ident: ref14 doi: 10.1038/s41598-018-19581-x – ident: ref46 doi: 10.1111/jcmm.15001 – ident: ref21 doi: 10.15829/1728-8800-2021-3119 – ident: ref28 doi: 10.3389/fphar.2019.01500 – ident: ref19 doi: 10.1016/S0735-1097(85)80380-6 – ident: ref20 doi: 10.1097/MCA.0000000000000115 – ident: ref49 doi: 10.4061/2011/532915 – ident: ref12 doi: 10.1038/emm.2014.81 – ident: ref11 – ident: ref50 doi: 10.1038/srep42916 – ident: ref10 doi: 10.1016/j.lfs.2018.06.001 – ident: ref29 doi: 10.1002/ctm2.585 – ident: ref1 doi: 10.1016/j.biocel.2022.106294 – ident: ref7 doi: 10.3390/biom10101354 – ident: ref2 doi: 10.1371/journal.pone.0137035 – ident: ref38 doi: 10.1371/journal.pone.0216363 – ident: ref41 doi: 10.1161/CIRCRESAHA.110.226357 – ident: ref3 doi: 10.1161/ATVBAHA.116.308905 – ident: ref13 doi: 10.1073/pnas.1105254108 – ident: ref45 doi: 10.3389/fphys.2019.00123 – ident: ref16 doi: 10.3389/fcvm.2022.826478 – ident: ref24 doi: 10.18632/oncotarget.18308 – ident: ref30 doi: 10.1002/jnr.24487 – ident: ref47 doi: 10.18632/aging.101766 – ident: ref5 doi: 10.1155/2016/4285942 – ident: ref34 doi: 10.3389/fcvm.2021.632392 – ident: ref4 doi: 10.1016/j.ehj.2004.03.005 – ident: ref32 doi: 10.1016/j.mrfmmm.2014.01.001 – ident: ref17 doi: 10.1016/j.pneurobio.2013.11.004 – ident: ref22 doi: 10.2217/bmm-2016-0282 – ident: ref42 doi: 10.1161/CIRCRESAHA.109.215566 – ident: ref27 doi: 10.1006/meth.2001.1262 – ident: ref26 doi: 10.1016/j.ymeth.2012.09.015 – ident: ref40 doi: 10.1016/j.devcel.2008.07.002 – ident: ref51 doi: 10.21614/jtmr-20-3-44 – ident: ref9 doi: 10.2174/1568026623666221221124530 – ident: ref37 doi: 10.3390/biom11070962 – ident: ref18 doi: 10.1016/j.bbrc.2009.06.075 – ident: ref23 doi: 10.3390/ijms21103485 – ident: ref15 doi: 10.3390/ijms21030700 – ident: ref33 doi: 10.1371/journal.pone.0181562 – ident: ref39 doi: 10.3390/diagnostics11020318 – ident: ref44 doi: 10.1371/journal.pone.0080738 – ident: ref36 doi: 10.1186/s13019-021-01700-x – ident: ref35 doi: 10.3389/fcvm.2021.770163 – ident: ref25 doi: 10.1016/j.jstrokecerebrovasdis.2021.106033 |
| SSID | ssj0001875324 |
| Score | 2.2814727 |
| Snippet | Aim.
To investigate the association of 10 circulating plasma microRNAs with collateral flow degree in chronic total occlusion (CTO) patients with coronary... Aim. To investigate the association of 10 circulating plasma microRNAs with collateral flow degree in chronic total occlusion (CTO) patients with coronary... |
| SourceID | doaj crossref |
| SourceType | Open Website Enrichment Source Index Database |
| StartPage | 4086 |
| SubjectTerms | chronic total occlusion coronary artery disease coronary collateral circulation microrna |
| Title | Association of plasma microRNA levels with different collateral circulation degree in chronic total occlusion patients with coronary artery disease: a pilot study |
| URI | https://doaj.org/article/be208b86d0b4485eb280b782781a99c4 |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Directory of Open Access Journals customDbUrl: eissn: 2619-0125 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001875324 issn: 1728-8800 databaseCode: DOA dateStart: 20050101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlp1xCS1Ky_WIOvYq4kmXJuaUlIfSQQ0hgb0Ya2bDgXS9b7yF_p780M7J28S2XXIUsjN7geU8evRHip1eWSH0ZZeW9kSUqlHXUSlahI35iI30TU5XvQ3X_XP5dmuWs1RfXhE32wNPGXYVWFS64KhaBlIQhIeiKQGnNul--rjE5gVIam4mpdLrCNHzqaGuVkxSkRb43Z5yqr46DFCSqJA3FV6lneWlm35_yzN1HcZYJItxML_ZJfNjtz8X_2S7C0MGWOO_aw5qr6R4fbqDn0p9_wIeqcGh5MkLCmG8Y94CrHeZGXRBb0tgtrDaAkzMujANRcBgQ-z0fnkE2W80LIpsc-N0LpPLPF8j_dK7Bw3bVDyMki9oL8Xx3-_TnXubuChJpwyqpa4wR0aIqo3U6GNvaoGJrvI2dRfYBpORviT_paBxpbu0xdJomRY-1KfRncbIZNu2lgEJ1pIPa0lBqK6MuvS06S1Bjh8rXzi2EPuxtg9l6nDtg9A1LEEakYUQaRqRhRBpGZCHk8antZL3xxvzfDNtxLhtnpwEKpyaHU_NWOH15j0W-itMUV6lO8Js4GXf79jtxlzH8SGH6CsRO6Xs |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+plasma+microRNA+levels+with+different+collateral+circulation+degree+in+chronic+total+occlusion+patients+with+coronary+artery+disease%3A+a+pilot+study&rft.jtitle=Kardiovaskuli%CD%A1a%EF%B8%A1rnai%CD%A1a%EF%B8%A1+terapii%CD%A1a%EF%B8%A1+i+profilaktika&rft.au=Kiseleva%2C+A.+V.&rft.au=Vasilyev%2C+D.+K.&rft.au=Soplenkova%2C+A.+G.&rft.au=Shukurov%2C+F.+B.&rft.date=2024-08-01&rft.issn=1728-8800&rft.eissn=2619-0125&rft.volume=23&rft.issue=7&rft.spage=4086&rft_id=info:doi/10.15829%2F1728-8800-2024-4086&rft.externalDBID=n%2Fa&rft.externalDocID=10_15829_1728_8800_2024_4086 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1728-8800&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1728-8800&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1728-8800&client=summon |